Therapeutic Applications of Microbial Enzymes in the Management of Kidney Stone Diseases-Reference-Cited by-同舟云学术

Therapeutic Applications of Microbial Enzymes in the Management of Kidney Stone Diseases

Published:2020 Issue: Volume: Page:319-329
ISSN:2512-1901
Container-title:Microorganisms for Sustainability
language:
Short-container-title:

Author:

Gupta Shruti,Kanwar Shamsher Singh

Publisher

Springer Singapore

Link

http://link.springer.com/content/pdf/10.1007/978-981-15-1710-5_13

Reference54 articles.

1. Abratt VR, Reid SJ (2010) Oxalate degradation bacteria of the human gut as probiotic in the management of kidney stones diseases. Adv Appl Microbiol 72:63–87

2. Aguilar C, Urzúa U, Koenig C, Vicuña R (1999) Oxalate oxidase from Ceriporiopsis subvermispora: biochemical and cytochemical studies. Arch Biochem Biophys 366:275–282

3. Alberta A, Tiwaria V, Paula E, Ganesana D, Ayyavub M, Kujura R, Ponnusamyc S, Shanmugamd K, Sasoe L, Selvama GS (2017) Expression of heterologous oxalate decarboxylase in HEK293 cells confers protection against oxalate induced oxidative stress as a therapeutic approach for calcium oxalate stone disease. J Enzyme Inhib Med Chem 32:426 433

4. Allison MJ, Cook HM (1981) Oxalate degradation by microbes of the large bowel of herbivores: the effect of dietary oxalate. Science 212:675–676

5. Anand R, Dorrestein P, Kinsland C, Begley T, Ealick S (2002) Structure of oxalate decarboxylase from Bacillus subtilis at 1. 75Å resolution. Biochemistry 41:7659–7669

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microbial Biopharmaceuticals in Urolithiasis Management and Treatment;Role of Microbes in Sustainable Development;2023

2. Molecular characterization and in silico analysis of oxalate decarboxylase of Pseudomonas sp. OXDC12;Journal of Biomolecular Structure and Dynamics;2022-01-10

3. Nanodrugs: A Futuristic Approach for Treating Nephrolithiasis;Biomedical Translational Research;2022